Academic Journals

Journals recently featuring the work of University of Arizona Cancer Center members:

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma; Improved Survival with Bevacizumab in Advanced Cervical Cancer
The New England Journal of Medicine, Feb. 20, 2014

Better therapeutic trials in ovarian cancer
Journal of the National Cancer Institute, March 13, 2014

Recent Studies from University of Arizona Add New Data to Pain, March 3, 2014

Evolution of Rodent Pheromones: A Review of the ABPs with Comparison to the ESPs and the MUPs
Journal of Biochemistry Research & Review, Aug. 2, 2013

Colorectal cancers soon after colonoscopy: a pooled multicohort analysis
GUT Medical Journal, June 21, 2013

SCFSlimb ubiquitin ligase suppresses condensin II–mediated nuclear reorganization by degrading Cap-H2
Journal of Cellular Biology, April 1, 2013 

Nucleolin Mediates MicroRNA-directed CSF-1 mRNA Deadenylation but Increases Translation of CSF-1 mRNA*
Molecular & Cellular Proteomics, March 7, 2013

Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer
Journal of Clinical Oncology, Jan. 22, 2013 

Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention
Cancer Prevention Research, Oct. 11, 2012

Myeloid Toxicity of Cancer Treatment
Journal of the Advanced Practitioner in Oncology, Aug. 16, 2012

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Nature, Aug. 12, 2012

Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer
New England Journal of Medicine, Aug. 2, 2012

Dietary polyamine intake and risk of colorectal adenomatous polyps
The American Journal of Clinical Nutrition, May 30, 2012

Dietary Supplements and Cancer Prevention: Balancing Potential Benefits Against Proven Harms
Journal of the National Cancer Institute, April 25, 2012

Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer
Clinical Cancer Research, March 15, 2012

Molecular Pathways: The Role of Primary Cilia in Cancer Progression and Therapeutics with a Focus on Hedgehog Signaling
Clinical Cancer Research, March 13, 2012

Aurora A inhibitor (MLN8237) plus Vincristine synergizes with Rituximab as a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma
Clinical Cancer Research, Feb. 28, 2012

Imexon Induces an Oxidative Endoplasmic Reticulum Stress Response in Pancreatic Cancer Cells
Molecular Cancer Research, Jan. 24, 2012

Demonstration that Drug-targeted Down-regulation of MYC in Non-Hodgkins Lymphoma Is Directly Mediated through the Promoter G-quadruplex*
The Journal of Biological Chemistry, Nov. 25, 2011

Th-1 Lymphocytes Induce Dendritic Cell Tumor Killing Activity by an IFN-γ–Dependent Mechanism
The Journal of Immunology, Nov. 9, 2011

Acquisition of resistance towards HYD1 correlates with a reduction in cleaved alpha 4 integrin expression and a compromised CAM-DR phenotype
Molecular Cancer Theraputics, Oct. 6, 2011

Understanding the dual nature of CD44 in breast cancer progression
Molecular Cancer Research, Oct. 4, 2011

Macrophage Dependent Cleavage of the Laminin Receptor α6β1 in Prostate Cancer
Molecular Cancer Research, Aug. 8, 2011

Cytotoxic Dendritic Cells Generated from Cancer Patients
The Journal of Immunology, July 29, 2011